Exploring how the ubiquitin proteasome system regulates copper homeostasis and its implications in disease
Discover how the first-in-class DOT1L PROTAC degrader MS2133 could revolutionize treatment for MLL-rearranged leukemia by completely eliminating the cancer-causing protein.
Exploring how myostatin promoter polymorphisms could revolutionize Bali cattle breeding programs through enhanced muscling and fat deposition traits.
Exploring how SCF E3 ubiquitin ligases function in cancer and the therapeutic strategies targeting these molecular complexes.
Discover how hypoxia-induced WSB1 protein drives osteosarcoma metastasis and the potential therapeutic strategies targeting this pathway.
Exploring how VHL protein dysfunction drives kidney cancer and the innovative therapies targeting this pathway.
Explore the groundbreaking science of targeted protein degradation (TPD), a revolutionary strategy that hijacks the cell's natural disposal systems to eliminate disease-causing proteins.
Exploring the crucial roles of TRAF3 and TRAF5 proteins in immune system regulation and their implications for disease treatment.
Discover how ubiquitin-like modifiers help plants survive salt stress through protein recycling, signaling, and autophagy mechanisms.
Exploring RPN13 as a novel therapeutic target for ovarian cancer treatment, focusing on its role in the proteasome system and potential to overcome chemotherapy resistance.